Evidence map›Paper›PMID 27687678›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2017

Comparing two lower-dose cisplatin programs for radio-chemotherapy of locally advanced head-and-neck cancers.

Dirk Rades, Daniel Seidl, Stefan Janssen, Primoz Strojan, Katarina Karner, Amira Bajrovic, Samer G Hakim, Barbara Wollenberg, Steven E Schild

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Dirk RadesDepartment of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. Rades.Dirk@gmx.net.
Daniel SeidlDepartment of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Stefan JanssenDepartment of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Primoz StrojanDepartment of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia.
Katarina KarnerDepartment of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia.
Amira BajrovicDepartment of Radiation Oncology, University Medical Center Eppendorf, Hamburg, Germany.
Samer G HakimDepartment of Oral and Maxillofacial Surgery, University of Lübeck, Lübeck, Germany.
Barbara WollenbergDepartment of Oto-Rhino-Laryngology and Head and Neck Surgery, University of Lübeck, Lübeck, Germany.
Steven E SchildDepartment of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, USA.
University of Lübeck · DEInstitute of Oncology Ljubljana · SIMayo Clinic in Arizona · USMedizinische Hochschule Hannover · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radio-chemotherapy is a common treatment for locally advanced squamous cell head-and-neck cancers (LA-SCCHN). Cisplatin (100 mg/m

Indexed as

Neoplasm StagingAntineoplastic AgentsCisplatinDose-Response Relationship, DrugFemaleHead and Neck NeoplasmsHumansMaleMiddle AgedRadiotherapy, AdjuvantRetrospective StudiesTreatment OutcomeAntineoplastic AgentsCisplatinLA-SCCHNLoco-regional controlLower-dose cisplatinRadio-chemotherapySurvivalToxicity

Identifiers

PMID27687678
OpenAlexW2524484254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.